Compositions and Methods for Modifying Cells
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsARIS N. ECONOMIDES, Andrew J. Murphy, David M. Valenzuela, David Frendewey, George D. Yancopoulos
Life of this patent
Estimating the term…
Loading patent…
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsARIS N. ECONOMIDES, Andrew J. Murphy, David M. Valenzuela, David Frendewey, George D. Yancopoulos
Estimating the term…
A method for engineering and utilizing large DNA vectors to target, via homologous recombination, and modify, in any desirable fashion, endogenous genes and chromosomal loci in eukaryotic cells. These large DNA targeting vectors for eukaryotic cells, termed LTVECs, are derived from fragments of cloned genomic DNA larger than those typically used by other approaches intended to perform homologous targeting in eukaryotic cells. Also provided is a rapid and convenient method of detecting eukaryotic cells in which the LTVEC has correctly targeted and modified the desired endogenous gene(s) or chromosomal locus (loci) as well as the use of these cells to generate organisms bearing the genetic modification.
A method for detecting the replacement of an endogenous allele with a modified allele in a cell, the method comprising:
A method for replacing an endogenous allele with a modified allele in a cell, the method comprising:
A composition comprising:
Dependencies are inferred from the claim text.